The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Open accessAbstract
Ewing sarcoma is an aggressive paediatric cancer of the bone and soft tissue. It results from a chromosomal translocation, predominantly t(11;22)(q24:q12), that fuses the N-terminal transactivation domain of the constitutively expressed EWSR1 protein with the C-terminal DNA binding domain of the rarely expressed FLI1 protein. Ewing sarcoma is highly sensitive to genotoxic agents such as etoposide, but the underlying molecular basis of this sensitivity is unclear. Here we show that Ewing sarcoma cells display alterations in regulation of damage-induced transcription, accumulation of R-loops and increased replication stress. In addition, homologous recombination is impaired in Ewing sarcoma owing to an enriched interaction between BRCA1 and the elongating transcription machinery. Finally, we uncover a role for EWSR1 in the transcriptional response to damage, suppressing R-loops and promoting homologous recombination. Our findings improve the current understanding of EWSR1 function, elucidate the mechanistic basis of the sensitivity of Ewing sarcoma to chemotherapy (including PARP1 inhibitors) and highlight a class of BRCA-deficient-like tumours.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Huang, D. W., Sherman, B. T., & Lempicki, R. A. (2009) · Nature Protocols · doi:10.1038/nprot.2008.211 · Cited by 35,890
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Yang, W., Soares, J., Greninger, P., Edelman, E. J., Lightfoot, H., Forbes, S., Bindal, N., Beare, D., Smith, J. A., Thompson, I. R., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks1111 · Cited by 4,051
XRCC3 promotes homology-directed repair of DNA damage in mammalian cells
Pierce, A. J., Johnson, R. D., Thompson, L. H., & Jasin, M. (1999) · Genes & Development · doi:10.1101/gad.13.20.2633 · Cited by 1,379
R Loops: From Transcription Byproducts to Threats to Genome Stability
Aguilera, A., & García-Muse, T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.04.009 · Cited by 1,026
Bouwman, P., Aly, A., Escandell, J. M., Pieterse, M., Bartkova, J., van der Gulden, H., Hiddingh, S., Thanasoula, M., Kulkarni, A., Yang, Q., et al. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1831 · Cited by 1,001
R-Loop Formation Is a Distinctive Characteristic of Unmethylated Human CpG Island Promoters
Ginno, P. A., Lott, P. L., Christensen, H. C., Korf, I., & Chédin, F. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.01.017 · Cited by 910
Escribano-Díaz, C., Orthwein, A., Fradet-Turcotte, A., Xing, M., Young, J. T. F., Tkáč, J., Cook, M. A., Rosebrock, A. P., Munro, M., Canny, M. D., et al. (2013) · Molecular Cell · doi:10.1016/j.molcel.2013.01.001 · Cited by 900
Phosphorylation and functions of the RNA polymerase II CTD
Phatnani, H. P., & Greenleaf, A. L. (2006) · Genes & Development · doi:10.1101/gad.1477006 · Cited by 752
Rad51-mediated replication fork reversal is a global response to genotoxic treatments in human cells
Zellweger, R., Dalcher, D., Mutreja, K., Berti, M., Schmid, J. A., Herrador, R., Vindigni, A., & Lopes, M. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201406099 · Cited by 677
Sanz, L. A., Hartono, S. R., Lim, Y. W., Steyaert, S., Rajpurkar, A., Ginno, P. A., Xu, X., & Chédin, F. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.05.032 · Cited by 557
BRCA1 Recruitment to Transcriptional Pause Sites Is Required for R-Loop-Driven DNA Damage Repair
Hatchi, E., Skourti-Stathaki, K., Ventz, S., Pinello, L., Yen, A., Kamieniarz-Gdula, K., Dimitrov, S., Pathania, S., McKinney, K. M., Eaton, M. L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.011 · Cited by 478
Riggi, N., Knoechel, B., Gillespie, S. M., Rheinbay, E., Boulay, G., Suvà, M. L., Rossetti, N. E., Boonseng, W. E., Oksuz, O., Cook, E. B., et al. (2014) · Cancer Cell · doi:10.1016/j.ccell.2014.10.004 · Cited by 445
Transcription as a source of genome instability
Kim, N., & Jinks-Robertson, S. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3152 · Cited by 305
Turc-Carel, C., Philip, I., Berger, M.-P., Philip, T., & Lenoir, G. M. (1984) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(84)90002-5 · Cited by 291
PARP-1 Inhibition as a Targeted Strategy to Treat Ewing's Sarcoma
Brenner, J. C., Feng, F. Y., Han, S., Patel, S., Goyal, S. V., Bou-Maroun, L. M., Liu, M., Lonigro, R., Prensner, J. R., Tomlins, S. A., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-3648 · Cited by 290
Hamperl, S., & Cimprich, K. A. (2014) · DNA Repair · doi:10.1016/j.dnarep.2014.03.023 · Cited by 262
Bertolotti, A., Melot, T., Acker, J., Vigneron, M., Delattre, O., & Tora, L. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.3.1489 · Cited by 261
Promiscuous partnerships in Ewing's sarcoma
Sankar, S., & Lessnick, S. L. (2011) · Cancer Genetics · doi:10.1016/j.cancergen.2011.07.008 · Cited by 258
Self-citationFUS binds the CTD of RNA polymerase II and regulates its phosphorylation at Ser2
Schwartz, J. C., Ebmeier, C. C., Podell, E. R., Heimiller, J., Taatjes, D. J., & Cech, T. R. (2012) · Genes & Development · doi:10.1101/gad.204602.112 · Cited by 238
The Ewing Sarcoma Protein Regulates DNA Damage-Induced Alternative Splicing
Paronetto, M. P., Miñana, B., & Valcárcel, J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.05.035 · Cited by 176
Oncogenic fusion protein EWS-FLI1 is a network hub that regulates alternative splicing
Selvanathan, S. P., Graham, G. T., Erkizan, H. V., Dirksen, U., Natarajan, T. G., Dakic, A., Yu, S., Liu, X., Paulsen, M. T., Ljungman, M. E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1500536112 · Cited by 168
Self-citationHu, Y., Petit, S. A., Ficarro, S. B., Toomire, K. J., Xie, A., Lim, E., Cao, S. A., Park, E., Eck, M. J., Scully, R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0891 · Cited by 167
Yang, L., Chansky, H. A., & Hickstein, D. D. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005739200 · Cited by 165
Sarcomas: genetics, signalling, and cellular origins. Part 1: The fellowship of TET
Riggi, N., Cironi, L., Suvà, M., & Stamenkovic, I. (2007) · The Journal of Pathology · doi:10.1002/path.2209 · Cited by 154
Ewing sarcoma gene EWS is essential for meiosis and B lymphocyte development
Li, K., Watford, W. T., Li, C., Parmelee, A., Bryant, M., Deng, C., O’Shea, J. J., & Lee, S. B. (2007) · Journal of Clinical Investigation · doi:10.1172/jci31222 · Cited by 146
Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage
Hill, S. J., Rolland, T., Adelmant, G., Xia, X., Owen, M., Dricot, A., Zack, T. I., Sahni, N., Jacob, Y., Hao, T., et al. (2014) · Genes & Development · doi:10.1101/gad.241620.114 · Cited by 113
Suzuki, Y., Holmes, J. B., Cerritelli, S. M., Sakhuja, K., Minczuk, M. A., Holt, I. J., & Crouch, R. J. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00619-10 · Cited by 104
BRCA1 Associates with Processive RNA Polymerase II
Krum, S. A., Miranda, G. A., Lin, C., & Lane, T. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m308418200 · Cited by 91
Ewing Sarcoma Protein: A Key Player in Human Cancer
Paronetto, M. P. (2013) · International Journal of Cell Biology · doi:10.1155/2013/642853 · Cited by 91
Efficacy of ATR inhibitors as single agents in Ewing sarcoma
Nieto-Soler, M., Morgado-Palacin, I., Lafarga, V., Lecona, E., Murga, M., Callén, E., Azorín, D., Alonso, J., Lopez-Contreras, A. J., Nussenzweig, A., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11643 · Cited by 91
Embree, L. J., Azuma, M., & Hickstein, D. D. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3229 · Cited by 66
Homotypic and heterotypic interactions of EWS, FLI1 and their oncogenic fusion protein
Spahn, L., Siligan, C., Bachmaier, R., Schmid, J. A., Aryee, D. N. T., & Kovar, H. (2003) · Oncogene · doi:10.1038/sj.onc.1206810 · Cited by 56
A Network of Conserved Damage Survival Pathways Revealed by a Genomic RNAi Screen
Ravi, D., Wiles, A. M., Selvaraj, B., Ruan, J., Leder, P., & Bishop, A. J. R. (2009) · PLoS Genetics · doi:10.1371/journal.pgen.1000527 · Cited by 51
Self-citationProfiling of the BRCA1 transcriptome through microarray and ChIP-chip analysis
Gorski, J. J., Savage, K. I., Mulligan, J. M., McDade, S. S., Blayney, J. K., Ge, Z., & Harkin, D. P. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr679 · Cited by 46
Wiles, A. M., Ravi, D., Selvaraj, B., & Bishop, A. J. R. (2008) · SLAS DISCOVERY · doi:10.1177/1087057108323125 · Cited by 37
Self-citationBRCA1 Loss Induces GADD153-Mediated Doxorubicin Resistance in Prostate Cancer
Luca, P. D., Vazquez, E. S., Moiola, C. P., Zalazar, F., Cotignola, J., Gueron, G., Gardner, K. L., & Siervi, A. D. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-11-0155 · Cited by 35
Cited by
Grünewald, T. G. P., Cidre-Aranaz, F., Surdez, D., Tomazou, E. M., de Álava, E., Kovar, H., Sorensen, P. H., Delattre, O., & Dirksen, U. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0003-x · Cited by 873
R-Loops as Cellular Regulators and Genomic Threats
Crossley, M. P., Bocek, M., & Cimprich, K. A. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.01.024 · Cited by 746
R Loops: From Physiological to Pathological Roles
García-Muse, T., & Aguilera, A. (2019) · Cell · doi:10.1016/j.cell.2019.08.055 · Cited by 697
Sources, resolution and physiological relevance of R-loops and RNA–DNA hybrids
Petermann, E., Lan, L., & Zou, L. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00474-x · Cited by 372
Zhang, C., Chen, L., Peng, D., Jiang, A., He, Y., Zeng, Y., Xie, C., Zhou, H., Luo, X., Liu, H., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.06.017 · Cited by 331
Metadata
- Authors
- Gorthi, A., Romero, J. C., Loranc, E., Cao, L., Lawrence, L. A., Goodale, E., Iniguez, A. B., Bernard, X., Masamsetti, V. P., Roston, S., Lawlor, E. R., Toretsky, J. A., Stegmaier, K., Lessnick, S. L., Chen, Y., & Bishop, A. J. R.
- Venue
- Nature
- Published
- 2018-03-07
- Volume
- 555
- Issue
- 7696
- Pages
- 387-391
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2792813139
- Cited by
- 329
- References
- 40
- FWCI
- 19.61
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.